An Official Website of the United States Government
PPMP as a Ceramide Catabolism Inhibitor for Chemotherapy
- Small Business Information
-
AVANTI POLAR LIPIDS, INC.AVANTI POLAR LIPIDS, INC. 700 INDUSTRIAL PARK DRIVE ALABASTER, AL 35007View profile »Woman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
- Phase 1
-
Fiscal Year: 2003Title: PPMP as a Ceramide Catabolism Inhibitor for ChemotherapyAgency: HHSContract: 1R41CA102842-01Award Amount: $249,947.00
Abstract:
DESCRIPTION (provided by applicant): Our goal is to develop 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) as a clinical inhibitor of ceremide catabolism, in order to enhance the anti-cancer activity of the cytotoxic retinoid, fenretinide (4-HPR). We have reported that 4-HPR increased ceramide in numerous pediatric and adult solid cancer and leukemia cell lines in vitro. We have also reported that PPMP, an inhibitor of glucosylceramide synthase and l-O-acylceramide synthase, further increased ceramide and synergized 4-HPR cytotoxicity. We hypothesize that intravenous or oral formulations of PPMP can achieve plasma and tissue levels that inhibit ceramide catabolism in vitro. We hypothesize that PPMP will enhance the anti-cancer effect of 4-HPR with tolerable systemic toxicity in vivo. We will: AIM 1. Identify the stereoisomer of PPMP that most effectively inhibits ceramide catabolism and increases 4-HPR cytotoxicity. AIM 2. Develop a cGMP process, and produce PPMP for pre-IND studies. AIM 3. Formulate PPMP for intravenous and/or oral delivery. AIM 4. Perform small animal pharmacokinetic and toxicology studies to support a Phase II STTR application to support IND-directed toxicology studies and cGMP PPMP manufacture for Phase I clinical trial. 4-HPR+PPMP represents a novel, p53-independent chemotherapy that is based upon the generation and manipulation of ceramide in vivo.Small Business Information at Submission:Business Contact:
2056632494Research Institution Information:Avanti Polar Lipids, Inc.
700 INDUSTRIAL PARK DR 700 INDUSTRIAL PARK DR Alabaster, AL 35007EIN/Tax ID: 630790131DUNS: N/ANumber of Employees: N/AWoman-Owned: NoMinority-Owned: NoHUBZone-Owned: NoCHILDREN'S HOSPITAL LOS ANGELES
4650 SUNSET BLVD
LOS ANGELES, CA 90027RI Type: Domestic nonprofit research organization
Award Information
|
Agency: Department of Health and Human Services |
Branch: N/A |
Award ID: 65244 |
Program Year/Program: 2003 / STTR |
|
Agency Tracking Number: CA102842 |
Solicitation Year: N/A |
Solicitation Topic Code: N/A |
Solicitation Number: N/A |